CELF2 and central nervous system cancer: Analyses correlating the expression of CELF2 against the expression of all 789 public NJs identified a greater percentage of NJs whose expression generally increased (average Pearson correlation coefficient of >0.10) with the increasing level of CELF2 expression across all glioma subtypes (Fig. 3i).